Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

774 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.
Satzger I, Völker B, Meier A, Schenck F, Kapp A, Gutzmer R. Satzger I, et al. Among authors: meier a. Am J Surg Pathol. 2007 Aug;31(8):1175-80. doi: 10.1097/PAS.0b013e3180341ebc. Am J Surg Pathol. 2007. PMID: 17667539
The use of immunohistochemistry with melanocytic markers such as HMB45 and Melan A increases the detection rate of micrometastases but there are also cases with isolated immunohistochemically positive cells (IPC). ...The mean follow-up was 38.1 months. By Kaplan-Meier …
The use of immunohistochemistry with melanocytic markers such as HMB45 and Melan A increases the detection rate of micrometastases bu …
Is there a therapeutic benefit of complete lymph node dissection in melanoma patients with low tumor burden in the sentinel node?
Satzger I, Meier A, Zapf A, Niebuhr M, Kapp A, Gutzmer R. Satzger I, et al. Among authors: meier a. Melanoma Res. 2014 Oct;24(5):454-61. doi: 10.1097/CMR.0000000000000081. Melanoma Res. 2014. PMID: 24811213
We analyzed the clinical course of 305 SLN-positive patients with a mean follow-up of 51.1 months by Kaplan-Meier analyses. Overall, 58/305 (17%) patients did not undergo CLND. ...The subgroup of patients with minimal tumor burden in SLN also did not benefit signifi …
We analyzed the clinical course of 305 SLN-positive patients with a mean follow-up of 51.1 months by Kaplan-Meier analyses. Ov …
Sentinel node dissection delays recurrence and prolongs melanoma-related survival: an analysis of 673 patients from a single center with long-term follow-up.
Satzger I, Meier A, Hoy L, Völker B, Kapp A, Hauschild A, Gutzmer R. Satzger I, et al. Among authors: meier a. Ann Surg Oncol. 2011 Feb;18(2):514-20. doi: 10.1245/s10434-010-1318-3. Epub 2010 Sep 14. Ann Surg Oncol. 2011. PMID: 20839060 Clinical Trial.
BACKGROUND: The status of the sentinel lymph node is an important predictor for survival in melanoma patients, but it is still unclear if early removal of micrometastases by sentinel lymph node dissection (SLND) alters survival. A large series of melanoma patients from …
BACKGROUND: The status of the sentinel lymph node is an important predictor for survival in melanoma patients, but it is still unclear if ea …
Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha.
Satzger I, Meier A, Schenck F, Kapp A, Hauschild A, Gutzmer R. Satzger I, et al. Among authors: meier a. Int J Cancer. 2007 Dec 1;121(11):2562-6. doi: 10.1002/ijc.22951. Int J Cancer. 2007. PMID: 17680564
A recent study suggested that melanoma patients developing autoantibodies or clinical manifestations of autoimmunity during adjuvant high-dose interferon alpha treatment had a significant survival benefit. ...In 2 patients (one with AIT and one with arthritis) the a …
A recent study suggested that melanoma patients developing autoantibodies or clinical manifestations of autoimmunity during adjuvant …
Parameters predicting prognosis in melanoma sentinel nodes.
Satzger I, Meier A, Alter M, Kapp A, Gutzmer R. Satzger I, et al. Among authors: meier a. J Clin Oncol. 2011 Sep 10;29(26):3588-90; author reply 3590-1. doi: 10.1200/JCO.2011.37.1112. Epub 2011 Aug 1. J Clin Oncol. 2011. PMID: 21810683 No abstract available.
774 results